Options

Aries I Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on July 9, 2021

Retrieved on: 
Thursday, July 8, 2021
Professional services, Finance, Money, Finance, Equity securities, Options, Corporate finance, Warrant, Aries, Economy

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into Class A ordinary shares and warrants.
  • Aries I Acquisition Corporation was founded by its Chairman, Thane Ritchie.
  • Randy Brinkley, CEO of Aries, said, Aries is well positioned at the intersection of several breakout technologies experiencing a massive growth inflection.

CSE Bulletin: New Listing - Choom Holdings Inc. Warrants (CHOO.WT)

Retrieved on: 
Thursday, July 8, 2021
Corporate finance, Options, Warrant

Toronto, Ontario--(Newsfile Corp. - le 8 juillet/July 2021) Choom Holdings Inc. Warrants (the "Warrants") have been approved for listing.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - le 8 juillet/July 2021) Choom Holdings Inc. Warrants (the "Warrants") have been approved for listing.
  • Each whole Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire one (1) Warrant Share upon payment of the Exercise Price of $0.12.
  • Les bons de souscription de Coom Holdings Inc. (les bons de souscription ) ont t approuvs pour inscription.
  • Voir l'acte relatif aux bons de souscription pour tous les dtails.

Angel Pond Holdings Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 9, 2021

Retrieved on: 
Thursday, July 8, 2021
Finance, Consulting, Banking, Professional services, Other Professional Services, Finance, Money, Equity securities, Options, Corporate finance, Financial economics, Warrant, Ticker symbol

Each unit consists of one Class A ordinary share and one-third of one redeemable warrant.

Key Points: 
  • Each unit consists of one Class A ordinary share and one-third of one redeemable warrant.
  • The Class A ordinary shares and warrants that are separated will trade on The New York Stock Exchange under the symbols POND and POND WS, respectively.
  • No fractional warrants will be issued upon the separation of the units and only whole warrants will trade.
  • Units that are not separated will continue to trade on The New York Stock Exchange under the symbol POND.U.

Harmony Announces Private Placement, Debt Settlements, Stock Compensations and Voting Results Of Annual General and Special Shareholders' Meeting

Retrieved on: 
Thursday, July 8, 2021
Finance, Money, Corporate finance, Equity securities, Stock market, Options, Warrant, Stock, Private placement

New York, New York--(Newsfile Corp. - July 8, 2021) - Harmony Energy Technologies Corporation ("Harmony" or the "Company") is pleased to announce the completion of a non-brokered private placement (the "Private Placement").

Key Points: 
  • New York, New York--(Newsfile Corp. - July 8, 2021) - Harmony Energy Technologies Corporation ("Harmony" or the "Company") is pleased to announce the completion of a non-brokered private placement (the "Private Placement").
  • Each Unit consists of one common stock of the Company and one common stock purchase warrant ("Warrant").
  • Each Warrant entitles its holder to purchase one common stock at the purchase price of $0.25 per share during an 36-month period beginning at the closing date.
  • The Company is also pleased to provide the results from its Annual and Special Shareholders' Meeting (the "AGM") held on July 8, 2021.

EWI Investors, LLC Increases Equity Stake in Environmental Waste International Inc. by Converting Note to Common Equity

Retrieved on: 
Wednesday, July 7, 2021
Corporate finance, Financial markets, Finance, Financial economics, Equity securities, Stock market, Options, Warrant, Promissory note, Stock, EWI, Shares outstanding

The Company previously entered a promissory note dated April 12, 2017 and amended on September 16, 2019 with EWI (the "Note"), of which Robert Savage, a Director of EWS, is the Managing Member.

Key Points: 
  • The Company previously entered a promissory note dated April 12, 2017 and amended on September 16, 2019 with EWI (the "Note"), of which Robert Savage, a Director of EWS, is the Managing Member.
  • The Note bears interest at a rate of 6% per annum, of which $101,775 of interest had accrued up to May 24, 2021.
  • Following the Debt Conversion, EWI Investors beneficially owns 53,477,266 common shares, representing approximately 20.7% of the issued and outstanding shares of EWS.
  • EWI Investors also owns 3,712,500 warrants and 425,000 options in the capital stock of the Company.

Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Wednesday, July 7, 2021
Inheritance, Labour law, Property law, Vesting, Law, Private law, Options, Articles, Corporate finance

These grants were made pursuant to the Companys 2021 Inducement Stock Incentive Plan, were approved by the Companys Inducement Grant Subcommittee of the board of directors, and were made as a material inducement to each employees acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.

Key Points: 
  • These grants were made pursuant to the Companys 2021 Inducement Stock Incentive Plan, were approved by the Companys Inducement Grant Subcommittee of the board of directors, and were made as a material inducement to each employees acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
  • The stock options have an exercise price of $28.60 per share, equal to the closing price of Translate Bios common stock on July 6, 2021.
  • The vesting of each grant is subject to the employees continued service with the Company through the applicable vesting date.
  • The inducement grants are subject to the terms and conditions of award agreements covering the grants and the Companys 2021 Inducement Stock Incentive Plan.

Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Wednesday, July 7, 2021
Inheritance, Labour law, Property law, Vesting, Options, Law, Private law, Corporate finance, Articles, Restricted stock

The stock options vest over four years, with 25% vesting on the employees start date and 1/36th of the remaining shares vesting monthly thereafter, subject to the employees continued employment on each such date.

Key Points: 
  • The stock options vest over four years, with 25% vesting on the employees start date and 1/36th of the remaining shares vesting monthly thereafter, subject to the employees continued employment on each such date.
  • The stock options have a 10-year term and are subject to the terms and conditions of the stock option agreement.
  • The Company granted the stock options as a material inducement to this employee for entering into employment with Chinook Therapeutics, Inc. in accordance with Nasdaq listing Rule 5635(c)(4).
  • Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Wednesday, July 7, 2021
Financial markets, Finance, Corporate finance, Financial economics, Stock market, Options, Equity securities, Fundamental analysis, Restricted stock, Stock, Exercise, NASDAQ

The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The employees received options to purchase 8,000 shares of Apellis common stock and 4,000 restricted stock units (RSUs).
  • The options have an exercise price of $67.80, which is equal to the closing price of Apellis common stock on July 1, 2021, the grant date of the options.
  • Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies.

Corsair Partnering Corporation Announces Closing of $250 Million Initial Public Offering

Retrieved on: 
Wednesday, July 7, 2021
Professional services, Communications, Other Professional Services, Finance, Consulting, Banking, Public relations, Investor relations, Financial markets, Finance, Money, Stock market, Equity securities, Corporate finance, Options, Warrant, Ticker symbol, Stock, New York Stock Exchange

Corsair Partnering Corporation (the Company) today announced the closing of its initial public offering of 25,000,000 units at a price of $10.00 per unit.

Key Points: 
  • Corsair Partnering Corporation (the Company) today announced the closing of its initial public offering of 25,000,000 units at a price of $10.00 per unit.
  • The units began trading on the New York Stock Exchange (NYSE) under the ticker symbol CORS.U on July 1, 2021.
  • Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share.
  • This press release contains statements that constitute forward-looking statements, including with respect to the Companys search for an initial partnering transaction.

B. Keast Family Holdings Inc. Acquires Shares from Seller

Retrieved on: 
Tuesday, July 6, 2021
Equity securities, Options, Corporate finance, BKF, Warrant, Share

Vancouver, British Columbia--(Newsfile Corp. - July 6, 2021) - B. Keast Family Holdings Inc. ("BKF") announced today that it has acquired (the "Acquisition") an aggregate of 227,500 common shares in the capital of 1246764 B.C.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - July 6, 2021) - B. Keast Family Holdings Inc. ("BKF") announced today that it has acquired (the "Acquisition") an aggregate of 227,500 common shares in the capital of 1246764 B.C.
  • Ltd. ("648" or the "Seller") pursuant to a share purchase agreement entered into between BKF and the Seller on July 6, 2021.
  • The Purchased Shares were purchased at a price of $0.0001 per Purchased Share for an aggregate price of $22.75.
  • BKF purchased the Purchased Shares for private investment purposes and may increase or decrease its beneficial ownership or control in 764 as circumstances or market conditions warrant.